Without standardized quality control, peptide content, purity, sterility, and stability cannot be assured
Once your levels stabilize, you may only have to get injections less often to keep your levels reasonable
The top dose produced 20.9% average weight loss over 72 weeks and 20.2% in a direct comparison with semaglutides 13.7%. Its second receptor, GIP, separates tirzepatide from approved single-receptor GLP-1 drugs and helps explain the larger population-level weight loss. That 20.9% came from participants averaging about 105 kg at a BMI of 38, most of whom were sedentary
Common abbreviation: 5-Amino-1MQ
Starting at 250-300mcg regardless of body weight, then adjusting based on response, often works better than jumping to weight-based higher doses